Regulatory documents:

• Protocols
• Clinical study reports (Phase 1-4)
• Investigator's brochures
• Clinical summaries
• IND, NDA, BLA
• Orphan drug applications
• 505(b)(2) applications
• Briefing Documents
• Informed Consents
• ​Narratives
• Annual reports
• Package inserts